Endogenous Interferences in Clinical Laboratory Tests : : Icteric, Lipemic and Turbid Samples / / Martin H. Kroll, Christopher R. McCudden.

The goal of clinical laboratories is to produce accurate information for clinical decision making in medicine. More than half of the medical decisions made depend on clinical laboratory tests. Patient safety represents an important and critical problem for laboratories. They need to assure that the...

Full description

Saved in:
Bibliographic Details
Superior document:Title is part of eBook package: De Gruyter DGBA Backlist Complete English Language 2000-2014 PART1
VerfasserIn:
Place / Publishing House:Berlin ;, Boston : : De Gruyter, , [2012]
©2012
Year of Publication:2012
Language:English
Series:Patient Safety ; 5
Online Access:
Physical Description:1 online resource (143 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 05822nam a22009615i 4500
001 9783110266221
003 DE-B1597
005 20210830012106.0
006 m|||||o||d||||||||
007 cr || ||||||||
008 210830t20122012gw fo d z eng d
010 |a 2012034007 
019 |a (OCoLC)1013963497 
020 |a 9783110266221 
024 7 |a 10.1515/9783110266221  |2 doi 
035 |a (DE-B1597)173424 
035 |a (OCoLC)853259053 
040 |a DE-B1597  |b eng  |c DE-B1597  |e rda 
041 0 |a eng 
044 |a gw  |c DE 
050 0 0 |a RB37  |b .K756 2013 
050 4 |a R 
072 7 |a MED047000  |2 bisacsh 
100 1 |a Kroll, Martin H.,   |e author.  |4 aut  |4 http://id.loc.gov/vocabulary/relators/aut 
245 1 0 |a Endogenous Interferences in Clinical Laboratory Tests :  |b Icteric, Lipemic and Turbid Samples /  |c Martin H. Kroll, Christopher R. McCudden. 
264 1 |a Berlin ;  |a Boston :   |b De Gruyter,   |c [2012] 
264 4 |c ©2012 
300 |a 1 online resource (143 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 0 |a Patient Safety ;  |v 5 
505 0 0 |t Frontmatter --   |t Preface --   |t Contents --   |t 1 Accuracy Goals for Laboratory Tests --   |t 2 Nature of Interferences --   |t 3 The Nature of Icteric Interference --   |t 4 The Nature of Lipemic and Turbidity Interferences --   |t 5 Measurement of Interference --   |t 6 Origin of Icteric Samples --   |t 7 Impact of Icterus --   |t 8 Origin of Lipemia and Turbidity --   |t 9 Impact of Lipemia/Turbidity --   |t 10 Endogenous Interferences in Clinical Laboratory Tests: Icteric, Lipemic and Turbid Samples --   |t 11 Reporting of Results --   |t 12 Analyte-dependent Interference --   |t Index 
506 0 |a restricted access  |u http://purl.org/coar/access_right/c_16ec  |f online access with authorization  |2 star 
520 |a The goal of clinical laboratories is to produce accurate information for clinical decision making in medicine. More than half of the medical decisions made depend on clinical laboratory tests. Patient safety represents an important and critical problem for laboratories. They need to assure that the information they deliver to physicians is accurate, and therefore safe for clinicians to use. Endogenous compounds can interfere with laboratory tests, decreasing accuracy and threatening patient safety. Elevated bilirubin (bilirubinemia) and elevated lipids (lipemia) are common conditions that cause significant interferences with laboratory results. Clinicians depend on laboratories to detect these endogenous interferences. Laboratories must have a means to detect these endogenous interferences, make decisions about reporting results, and evaluate their impact. Most clinical pathology books provide only an abbreviated introduction to the subject, or provide a long list of references, without the necessary foundation for evaluating their significance. Package inserts typically provide scant information. This book provides the empirical and theoretical foundation for these interferences, describes the clinical settings where they occur, and explains their evaluation and detection, allowing the laboratory to interpret the available data on interferences and make the appropriate decision to effectively report test results while protecting patient safety. 
538 |a Mode of access: Internet via World Wide Web. 
546 |a In English. 
588 0 |a Description based on online resource; title from PDF title page (publisher's Web site, viewed 30. Aug 2021) 
650 0 |a Clinical biochemistry. 
650 0 |a Diagnosis, Laboratory. 
650 4 |a Behandlungsfehler. 
650 4 |a Interferenz. 
650 4 |a Klinische Pathologie. 
650 4 |a Labormedizin. 
650 4 |a Patientensicherheit. 
650 7 |a MEDICAL / Laboratory Medicine.  |2 bisacsh 
653 |a Bilirubinemia. 
653 |a Clinical Pathology. 
653 |a Interference. 
653 |a Lipemia. 
653 |a Patient Safety. 
700 1 |a McCudden, Christopher R.,   |e author.  |4 aut  |4 http://id.loc.gov/vocabulary/relators/aut 
773 0 8 |i Title is part of eBook package:  |d De Gruyter  |t DGBA Backlist Complete English Language 2000-2014 PART1  |z 9783110238570 
773 0 8 |i Title is part of eBook package:  |d De Gruyter  |t DGBA Backlist Medicine and Life Sciences 2000-2014 (EN)  |z 9783110238495 
773 0 8 |i Title is part of eBook package:  |d De Gruyter  |t DGBA Medicine and Life Sciences 2000 - 2014  |z 9783110637915  |o ZDB-23-GML 
773 0 8 |i Title is part of eBook package:  |d De Gruyter  |t E-BOOK GESAMTPAKET / COMPLETE PACKAGE 2012  |z 9783110288995  |o ZDB-23-DGG 
773 0 8 |i Title is part of eBook package:  |d De Gruyter  |t E-BOOK PACKAGE MEDICINE 2012  |z 9783110293807  |o ZDB-23-DME 
773 0 8 |i Title is part of eBook package:  |d De Gruyter  |t E-BOOK PAKET MEDIZIN 2012  |z 9783110293791  |o ZDB-23-DMD 
776 0 |c print  |z 9783110266207 
856 4 0 |u https://doi.org/10.1515/9783110266221 
856 4 0 |u https://www.degruyter.com/isbn/9783110266221 
856 4 2 |3 Cover  |u https://www.degruyter.com/cover/covers/9783110266221.jpg 
912 |a 978-3-11-023849-5 DGBA Backlist Medicine and Life Sciences 2000-2014 (EN)  |c 2000  |d 2014 
912 |a 978-3-11-023857-0 DGBA Backlist Complete English Language 2000-2014 PART1  |c 2000  |d 2014 
912 |a EBA_BACKALL 
912 |a EBA_CL_MDPM 
912 |a EBA_DGALL 
912 |a EBA_EBACKALL 
912 |a EBA_EBKALL 
912 |a EBA_ECL_MDPM 
912 |a EBA_EEBKALL 
912 |a EBA_ESTMALL 
912 |a EBA_STMALL 
912 |a GBV-deGruyter-alles 
912 |a PDA12STME 
912 |a PDA13ENGE 
912 |a PDA18STMEE 
912 |a PDA5EBK 
912 |a ZDB-23-DGG  |b 2012 
912 |a ZDB-23-DMD  |b 2012 
912 |a ZDB-23-DME  |b 2012 
912 |a ZDB-23-GML  |c 2000  |d 2014